CDKN1C Gene Beckwith-Wiedemann Syndrome NGS Genetic DNA Test
Comprehensive Genetic Testing for Cancer Risk Assessment
The CDKN1C Gene Beckwith-Wiedemann Syndrome NGS Genetic DNA Test represents a breakthrough in precision medicine, offering advanced genetic screening for individuals at risk of inherited cancer syndromes. This sophisticated diagnostic tool utilizes cutting-edge Next-Generation Sequencing (NGS) technology to analyze the CDKN1C gene, which plays a crucial role in cell cycle regulation and tumor suppression.
What Does This Test Measure?
This comprehensive genetic test specifically targets the CDKN1C gene, detecting mutations and variations that are associated with Beckwith-Wiedemann syndrome (BWS). The test identifies:
- Pathogenic variants in the CDKN1C gene
- Single nucleotide polymorphisms (SNPs)
- Insertions and deletions affecting gene function
- Epigenetic modifications impacting gene expression
- Genetic markers associated with increased cancer susceptibility
Who Should Consider This Test?
This genetic screening is particularly recommended for individuals presenting with:
- Clinical features of Beckwith-Wiedemann syndrome
- Macroglossia (enlarged tongue)
- Omphalocele or umbilical abnormalities
- Neonatal hypoglycemia
- Hemihypertrophy (asymmetric overgrowth)
- Family history of childhood cancers
- Personal history of Wilms tumor or hepatoblastoma
- Unexplained overgrowth patterns
- Multiple family members with similar developmental concerns
Benefits of Genetic Testing
Undergoing the CDKN1C genetic test provides numerous advantages:
- Early Risk Identification: Detect genetic predispositions before symptoms manifest
- Personalized Surveillance: Enable targeted cancer screening protocols
- Family Planning Guidance: Inform reproductive decisions and genetic counseling
- Proactive Medical Management: Implement preventive healthcare strategies
- Peace of Mind: Reduce uncertainty through definitive genetic information
- Comprehensive Analysis: NGS technology provides thorough genetic assessment
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our expert genetic counselors:
- Positive Result: Indicates presence of CDKN1C mutation, requiring specialized medical follow-up and cancer surveillance
- Negative Result: No pathogenic variants detected, though continued monitoring may be recommended based on clinical presentation
- Variant of Uncertain Significance: Requires additional family studies and clinical correlation
- Carrier Status: Important for family planning and genetic counseling purposes
Test Details and Pricing
| Test Feature | Details |
|---|---|
| Test Name | CDKN1C Gene Beckwith-Wiedemann Syndrome NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) Technology |
Pre-Test Requirements
Before scheduling your test, please ensure:
- Complete clinical history documentation
- Genetic counseling session to discuss implications
- Family pedigree chart development
- Understanding of potential outcomes and next steps
Nationwide Accessibility
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities nationwide.
Take Control of Your Genetic Health
Don’t let uncertainty about your genetic health create unnecessary anxiety. The CDKN1C Gene Beckwith-Wiedemann Syndrome NGS Genetic DNA Test provides the clarity you need to make informed healthcare decisions. Our team of genetic specialists and oncologists are ready to support you through every step of the testing process.
Ready to schedule your genetic test? Call our dedicated genetic counseling team today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic health and protecting your future.
